当前位置:首页 - 行情中心 - 新光药业(300519) - 财务分析 - 现金流量表

新光药业

(300519)

  

流通市值:16.59亿  总市值:23.26亿
流通股本:1.14亿   总股本:1.60亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金94,519,204.9270,171,742.76204,216,742.19141,551,545.15
  收到其他与经营活动有关的现金1,077,327.3612,659,931.3112,460,655.6611,185,643.07
  经营活动现金流入小计95,596,532.26282,831,674.07216,677,397.85152,737,188.22
  购买商品、接受劳务支付的现金14,122,978.39122,907,289.196,969,962.2567,224,518.55
  支付给职工以及为职工支付的现金10,316,078.7735,584,418.5226,634,509.2119,280,341.97
  支付的各项税费12,924,641.4433,592,144.425,197,618.4918,992,938.03
  支付其他与经营活动有关的现金6,429,139.4221,823,327.4217,287,251.8910,412,245.68
  经营活动现金流出小计43,792,838.02213,907,179.44166,089,341.84115,910,044.23
  经营活动产生的现金流量净额51,803,694.2468,924,494.6350,588,056.0136,827,143.99
二、投资活动产生的现金流量:
  收回投资收到的现金6,880,000---
  取得投资收益收到的现金1,059,551.055,941,645.953,080,095.342,293,253.87
  处置固定资产、无形资产和其他长期资产收回的现金净额-29,50027,00027,000
  收到的其他与投资活动有关的现金140,000,000635,000,000345,000,000235,000,000
  投资活动现金流入小计147,939,551.05640,971,145.95348,107,095.34237,320,253.87
  购建固定资产、无形资产和其他长期资产支付的现金53,746.753,475,750.93,480,119.273,241,927.27
  支付其他与投资活动有关的现金90,000,000850,000,000560,000,000420,000,000
  投资活动现金流出小计90,053,746.75853,475,750.9563,480,119.27423,241,927.27
  投资活动产生的现金流量净额57,885,804.3-212,504,604.95-215,373,023.93-185,921,673.4
三、筹资活动产生的现金流量:
  收到其他与筹资活动有关的现金-1,000,0001,000,0001,000,000
  筹资活动现金流入平衡项目-000
  筹资活动现金流入小计-1,000,0001,000,0001,000,000
  分配股利、利润或偿付利息支付的现金-48,000,00048,000,00048,000,000
  支付其他与筹资活动有关的现金-1,000,0001,000,0001,000,000
  筹资活动现金流出平衡项目-000
  筹资活动现金流出小计-49,000,00049,000,00049,000,000
  筹资活动产生的现金流量净额平衡项目-000
  筹资活动产生的现金流量净额--48,000,000-48,000,000-48,000,000
五、现金及现金等价物净增加额109,689,498.54-191,580,110.32-212,784,967.92-197,094,529.41
  加:期初现金及现金等价物余额311,836,015.14503,416,125.46503,416,125.46503,416,125.46
  期末现金及现金等价物余额421,525,513.68311,836,015.14290,631,157.54306,321,596.05
补充资料:
  净利润-54,211,458.52-31,907,696.41
  资产减值准备-435,419.57-177,676.58
  固定资产和投资性房地产折旧-14,445,503.35-7,459,233.05
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-14,445,503.35-7,459,233.05
  无形资产摊销-290,623.16-145,311.58
  处置固定资产、无形资产和其他长期资产的损失-3,722.27-3,722.27
  固定资产报废损失-42,236.22-16,406.3
  投资损失--5,630,250.11--2,185,287.2
  递延所得税-211,038.78-88,019.7
  其中:递延所得税资产减少-211,038.78-88,019.7
  存货的减少-25,633,500.64-7,563,721.93
  经营性应收项目的减少-4,926,744.05-4,345,749.55
  经营性应付项目的增加--25,442,627.08--12,647,916.64
  现金的期末余额-311,836,015.14-306,321,596.05
  减:现金的期初余额-503,416,125.46-503,416,125.46
  现金及现金等价物的净增加额--191,580,110.32--197,094,529.41
公告日期2026-04-212026-04-212025-10-282025-08-26
审计意见(境内)标准无保留意见
TOP↑